AAAAAA
Results:
1-7
|
Results: 7
Authors:
VAUGEOIS JM
PASSERA G
ZUCCARO F
COSTENTIN J
Citation: Jm. Vaugeois et al., INDIVIDUAL-DIFFERENCES IN RESPONSE TO IMIPRAMINE IN THE MOUSE TAIL SUSPENSION TEST, Psychopharmacology, 134(4), 1997, pp. 387-391
Authors:
VAUGEOIS JM
ELYACOUBI M
COSTENTIN J
LEDENT C
PARMENTIER M
Citation: Jm. Vaugeois et al., MICE NOT AROUSED BY CAFFEINE, MS. Medecine sciences, 13(12), 1997, pp. 1496-1498
Authors:
LEDENT C
VAUGEOIS JM
SCHIFFMANN SN
PEDRAZZINI T
ELYACOUBI M
VANDERHAEGHEN JJ
COSTENTIN J
HEATH JK
VASSART G
PARMENTIER M
Citation: C. Ledent et al., AGGRESSIVENESS, HYPOALGESIA AND HIGH BLOOD-PRESSURE IN MICE LACKING THE ADENOSINE A(2A) RECEPTOR, Nature, 388(6643), 1997, pp. 674-678
Authors:
THIBAUT F
BONNET JJ
VAUGEOIS JM
COSTENTIN J
Citation: F. Thibaut et al., PHARMACOLOGICAL MODIFICATIONS OF DOPAMINE TRANSMISSION DO NOT INFLUENCE THE STRIATAL IN-VIVO BINDING OF [H-3] MAZINDOL OR [H-3] COCAINE IN MICE, Neuroscience letters, 205(3), 1996, pp. 145-148
Authors:
VAUGEOIS JM
POUHE D
ZUCCARO F
COSTENTIN J
Citation: Jm. Vaugeois et al., INDIRECT DOPAMINE AGONISTS EFFECTS ON DESPAIR TEST - DISSOCIATION FROM HYPERACTIVITY, Pharmacology, biochemistry and behavior, 54(1), 1996, pp. 235-239
Authors:
THIBAUT F
VAUGEOIS JM
BONNET JJ
COSTENTIN J
Citation: F. Thibaut et al., IN-VIVO STRIATAL BINDING OF THE D-1 ANTAGONIST SCH-23390 IS NOT MODIFIED BY CHANGES IN DOPAMINERGIC TRANSMISSION, Neuropharmacology, 35(3), 1996, pp. 267-272
Authors:
VAUGEOIS JM
ODIEVRE C
LOISEL L
COSTENTIN J
Citation: Jm. Vaugeois et al., A GENETIC MOUSE MODEL OF HELPLESSNESS SENSITIVE TO IMIPRAMINE, European journal of pharmacology, 316(2-3), 1996, pp. 1-2
Risultati:
1-7
|